University of Paris-Saclay-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2020

  1. Repurposing infectious disease vaccines for intratumoral immunotherapy

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

2017

  1. Predictors of responses to immune checkpoint blockade in advanced melanoma

    Nature Communications, Vol. 8, Núm. 1

  2. Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody

    Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508